Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-05-31Clinical Trial Update: Randomized Controlled Trial of the Effectiveness of Group Treatment With War-Exposed Bosnian Adolescents [NA]
This document reports the completion of a randomized controlled trial evaluating the effectiveness of group treatment for war-exposed Bosnia…
-
CLINICAL_TRIALS trial_result · 2007-05-28Clinical Trial Update: Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects [Phase 3]
A Phase 3 trial completed to evaluate whether DVS SR and duloxetine affect the pharmacokinetics of desipramine in healthy subjects.
-
CLINICAL_TRIALS trial_result · 2007-05-28Clinical Trial Update: Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) [Phase 4]
The update confirms Eli Lilly's Phase 4 LEAPS trial for Major Depressive Disorder has completed. It lists the sponsor and condition but does…
-
CLINICAL_TRIALS trial_result · 2007-05-28Clinical Trial Update: Study Evaluating Effexor XR in Elderly Patients With Major Depression. [Phase 3]
A Phase 3 trial evaluating Effexor XR (venlafaxine extended release) for major depressive disorder in elderly patients has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-25Clinical Trial Update: Depression and Increased Health Services Utilization Among Elderly Primary Care Patients
This clinical trial update reports on depression in elderly primary care patients and its association with increased health services utiliza…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-05-24FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for fluoxetine, authorizing changes to the product's labeling.
-
CLINICAL_TRIALS trial_result · 2007-05-24Clinical Trial Update: Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression. [Phase 3]
A Phase 3 long-term safety study of venlafaxine extended-release (Effexor XR) in adults with major depressive disorder has been completed.
-
CLINICAL_TRIALS trial_result · 2007-05-24Clinical Trial Update: Study Evaluating Effexor XR for Major Depression. [Phase 3]
A Phase 3 clinical trial evaluating Effexor XR for major depressive disorder has completed, with Wyeth now a wholly owned subsidiary of Pfiz…
-
CLINICAL_TRIALS research · 2007-05-22Clinical Trial Update: AIMHI NT Relapse Prevention Trial [NA]
AIMHI NT Relapse Prevention Trial update (NCT00192582) sponsored by Menzies School of Health Research with listed conditions including schiz…
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Study of Duloxetine in Elderly Patients With Major Depressive Disorder [Phase 3]
Duloxetine was studied in a Phase 3 trial in elderly patients with major depressive disorder. The trial status is completed, with an update …
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Duloxetine vs. Active Comparator for the Treatment of Depression [Phase 4]
Phase 4 clinical trial update comparing duloxetine with an active comparator for depression has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Duloxetine vs. Active Comparator in the Treatment of Patients With Depression [Phase 4]
A Phase 4 trial comparing duloxetine with an active comparator in patients with depression has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-03Clinical Trial Update: Yoga Breath Program and Client-Centered Exposure for Relief of PTSD in Tsunami Victims [Phase 3]
Phase 3 clinical trial evaluating a Yoga Breath Program with client-centered exposure to relieve posttraumatic stress disorder and depressio…
-
FDA approval · 2007-05-01FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, authorizing the generic product under an …
-
FDA approval · 2007-04-30FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved ScieGen Pharmaceuticals Inc.'s sertraline hydrochloride as a generic under an Original Abbreviated New Drug Application for the…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism [Phase 3]
A Phase 3 clinical trial evaluating ziprasidone for psychiatric symptoms associated with alcoholism has completed.
-
CLINICAL_TRIALS research · 2007-04-20Clinical Trial Update: A Controlled Study to Assess the Effectiveness of Aerobic Exercise as an Augmentation Therapy for Inpatients With Major Depressive Disorder [NA]
This document is a clinical trial update evaluating aerobic exercise as an augmentation therapy for inpatients with major depressive disorde…
-
CLINICAL_TRIALS trial_result · 2007-04-17Clinical Trial Update: Wellbutrin XL, Major Depressive Disorder and Breast Cancer [Phase 4]
A Phase 4 clinical trial update reports the completion of a study evaluating Wellbutrin XL (bupropion) for major depressive disorder in pati…
-
CLINICAL_TRIALS trial_result · 2007-04-16Clinical Trial Update: Priming rTMS In Major Depression [NA]
The clinical trial evaluating priming repetitive transcranial magnetic stimulation for major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-16Clinical Trial Update: A Randomised Double-Blind Trial of Targeted Repetitive Transcranial Magnetic Stimulation in Major Depressive Disorder [NA]
A randomized double-blind trial of targeted repetitive transcranial magnetic stimulation for Major Depressive Disorder has completed, accord…
-
FDA label_change · 2007-04-09FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)
FDA approved a supplemental application for mirtazapine from Aurolife Pharma LLC, indicating changes related to labeling or related manufact…
-
FDA approval · 2007-04-09FDA Approved: CITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic formulation of citalopram hydrobromide from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2007-03-27Clinical Trial Update: Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder [Phase 3]
A Phase 3 trial evaluating DVS-233 for Major Depressive Disorder has completed.
-
FDA approval · 2007-03-27FDA Approved: CITALOPRAM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's original ANDA for Citalopram, a generic antidepressant, indicating approval for use in major …
-
FDA approval · 2007-03-26FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Sun Pharmaceutical Industries' generic mirtazapine.